Pressure overload and myocardial infarction are associated with markedly increased POSTN expression in animal models and POSTN has been proposed as an emerging therapeutic target to halt or reduce subsequent cardiac fibrosis [26–29]. The gene discussed is POSTN; the disease is myocardial infarction.